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Abstract
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. Several
functions have been proposed for the Escherichia coli DNA polymerase IV (pol IV). Although much
research has focused on a potential role for pol IV in assisting pol III replisomes in the bypass of lesions,
pol IV is rarely found at the replication fork in vivo. Pol IV is expressed at increased levels in E. coli cells
exposed to exogenous DNA damaging agents, including many commonly used antibiotics. Here we
present live-cell single-molecule microscopy measurements indicating that double-strand breaks induced
by antibiotics strongly stimulate pol IV activity. Exposure to the antibiotics ciprofloxacin and trimethoprim
leads to the formation of double strand breaks in E. coli cells. RecA and pol IV foci increase after
treatment and exhibit strong colocalization. The induction of the SOS response, the appearance of RecA
foci, the appearance of pol IV foci and RecA-pol IV colocalization are all dependent on RecB function. The
positioning of pol IV foci likely reflects a physical interaction with the RecA* nucleoprotein filaments that
has been detected previously in vitro. Our observations provide an in vivo substantiation of a direct role
for pol IV in double strand break repair in cells treated with double strand break-inducing antibiotics.
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Single-molecule live-cell imaging reveals
RecB-dependent function of DNA polymerase IV
in double strand break repair
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ABSTRACT

INTRODUCTION

Several functions have been proposed for the Escherichia coli DNA polymerase IV (pol IV). Although
much research has focused on a potential role for pol
IV in assisting pol III replisomes in the bypass of lesions, pol IV is rarely found at the replication fork in
vivo. Pol IV is expressed at increased levels in E. coli
cells exposed to exogenous DNA damaging agents,
including many commonly used antibiotics. Here we
present live-cell single-molecule microscopy measurements indicating that double-strand breaks induced by antibiotics strongly stimulate pol IV activity. Exposure to the antibiotics ciprofloxacin and
trimethoprim leads to the formation of double strand
breaks in E. coli cells. RecA and pol IV foci increase
after treatment and exhibit strong colocalization. The
induction of the SOS response, the appearance of
RecA foci, the appearance of pol IV foci and RecApol IV colocalization are all dependent on RecB function. The positioning of pol IV foci likely reflects a
physical interaction with the RecA* nucleoprotein filaments that has been detected previously in vitro.
Our observations provide an in vivo substantiation of
a direct role for pol IV in double strand break repair in
cells treated with double strand break-inducing antibiotics.

DNA polymerase IV (pol IV), encoded by dinB, is one of
three error-prone DNA polymerases to be produced at increased levels in Escherichia coli cells that experience DNA
damage (1–3). In vitro, pol IV is capable of translesion
synthesis (TLS) on a variety of different lesion-containing
DNA substrates (4–10). The most commonly discussed
function for pol IV within cells is TLS at stalled replication forks, which may help to maintain chromosomal replication in cells experiencing DNA damage (11–15). However, there is significant evidence that pol IV participates in
other pathways, including recombinational repair (16–24)
and transcription-coupled TLS (25–28). The recruitment of
pol IV to the processivity factor ␤ strongly depends on the
source of DNA damage (29), indicating that ultimately the
type of DNA lesion and changes in metabolism may affect
which repair pathway(s) pol IV participates in (10).
We recently completed a single-molecule study of fluorescently tagged pol IV in live E. coli cells (30), providing
direct evidence that exposure to various DNA-damaging
agents (ciprofloxacin, UV light and methyl methanesulfonate [MMS]) leads to the upregulation of pol IV production. Damage-induced upregulation of pol IV is triggered
due to SOS induction (31). Following exposure to various
DNA-damaging agents, we also detected the binding of individual pol IV molecules to the nucleoid, which presented
as punctate foci in fluorescence images (30). Focus formation required the catalytic activity of pol IV. Most interest-
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induces the formation of ssDNA gaps behind replication
forks, which are subsequently converted to DSBs by ROS.
Given that thymineless death and trimethoprim-induced
death share common features (44,45), it is plausible that a
similar pathway operates in trimethoprim-treated cells.
For both ciprofloxacin and trimethoprim treatments, we
show that levels of SOS-associated pol IV expression and
the formation of pol IV foci correlate with the number
of DSBs detected using a fluorescent MuGam probe. We
found that SOS induction and pol IV focus formation are
highly dependent on the RecBCD pathway. The presence
of RecA*-like structures in cells is sufficient to promote the
binding of pol IV to the nucleoid, even in the absence of
exogenous DNA damage. The observations strongly suggest that in cells treated with the DSB-promoting antibiotics
ciprofloxacin and trimethoprim, the primary substrates for
pol IV in cells are DSB repair intermediates.
MATERIALS AND METHODS
Strain construction
Strains used in this study are summarized in Table 1. Plasmids are summarized in Table 2.
EAW102 is E. coli K-12 MG1655 recB and was constructed using λRED recombination. The kanamycin resistance marker in EAW102 was removed via FLP-FRT recombination (46) using the plasmid pLH29 to obtain the
kanamycin-sensitive variant HG356.
EAW693 is E. coli K-12 MG1655 recF recO
recR and was constructed following three λRED recombinations. Three P1 phage lysates were raised,
using strains constructed in a previous study (47):
(i) EAW114 (recO::KanR ), (ii) EAW629 (recF::KanR )
and (iii) EAW669 (recR::KanR ). The kanamycin resistance was cured after each transduction step using
FLP-FRT recombination (46) to obtain the kanamycinsensitive variants. Finally, a kanamycin-sensitive variant
of EAW693 (recF::FRT recO::FRT recR::FRT) was
produced.
The SOS-uninducible strain RW1568 was made by P1
transduction of lexA3(ind− ) malB::Tn9 from DE407 (48)
into MG1655, selecting for selecting for chloramphenicol
resistance and then screening for lexA3(ind− ) associated
UV sensitivity. For testing sensitivites to DNA damaging
agents, the umuDC strain RW880 was constructed by P1
transduction of umuDC595::cat from RW120 (49) into
MG1655, selecting for chloramphenicol resistance.
EAW1144 is E. coli K-12 MG1655 dinB-YPet dnaXmKate2 sulA− lexA51(Def) recB and was constructed
in three steps. First, sulA− FRT-Kan-FRT was P1 transduced into EAW643 (KanS ) using a P1 lysate grown on
EAW13 (50) to obtain the strain EAW1134. Second, Kan
cassette was removed using FLP recombinase, which was
expressed from pLH29 (46). Third, lexA51(Def) malB::Tn9
was transduced into EAW1134 using a P1 lysate grown
on DE406 (51) to obtain the strain EAW1141. A recB
derivative, EAW1143, was prepared by transducing recB
FRT-KanR-FRT into EAW1141 using P1 lysate grown
on EAW102. All mutations introduced were confirmed by
polymerase chain reaction (PCR).
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ingly, the study revealed that only 10% of the pol IV foci occurred in the vicinity of replisomes (a colocalization threshold of 218 nm was used; (30)), suggesting that in cells treated
with a range of DNA-damaging agents, many of the binding sites for pol IV on the nucleoid are located away from
replication forks, potentially at sites of DSB repair (10).
In E. coli, DSBs are predominantly repaired through the
RecBCD pathway (for a review see (32)). Once formed,
DSBs are end-resected by the RecBCD helicase-nuclease
complex, generating 3 single-stranded DNA overhangs.
These serve as substrates for loading of the recombinase
RecA, generating nucleoprotein filaments denoted RecA*.
These filaments facilitate repair of the break via homologous recombination reactions. RecA* filaments are also
formed during the repair of single-stranded DNA (ssDNA)
gaps via the RecF pathway (33). Several lines of evidence
indicate that pol IV can play a role during DSB repair (16–
23,34–38). When expressed from a low-copy plasmid, fluorescently labelled pol IV colocalizes with RecA extensively
at sites of induced chromosomal DSBs (23). Several genetic
studies have demonstrated that the gene encoding pol IV,
dinB, is required for both induced and spontaneous errorprone DSB repair (18,20,34–37). In vitro studies have also
linked pol IV to RecA-mediated recombination, showing
that pol IV efficiently utilizes model D-loop recombination
intermediates (21,22). Additionally, pol IV physically interacts with the RecA protein in vitro (8,38). The results of a recent study indicate that pol IV-dependent error-prone break
repair is a major pathway underlying increased rates of mutagenesis in cells treated with ciprofloxacin at sub-inhibitory
concentrations (39). The study revealed that ciprofloxacininduced mutagenesis is concentrated within a distinct subpopulation of cells that express high levels of RpoS, brought
on by elevated production of reactive oxygen species (ROS).
Here, we extended our single-molecule fluorescence microscopy study (30) to investigate whether the formation
and processing of DSBs influence the regulation of pol IV
expression levels and the formation of pol IV foci on the nucleoid. We chose to investigate two antibiotics, ciprofloxacin
and trimethoprim, that each induce DSB formation, albeit via entirely different mechanisms. Ciprofloxacin is
an inhibitor of the type II topoisomerases DNA gyrase
and topoisomerase IV (40). Ciprofloxacin, like other (fluoro)quinolones, traps a DNA-cleaved intermediate state of
the topoisomerase cycle in a quinolone-stabilized cleavage complex, which inhibits replication fork progression
and induces DSB formation through multiple mechanisms
(41,42). Trimethoprim induces DSBs through mechanisms
that involve ROS (43,44). By inhibiting folate biosynthesis,
trimethoprim treatment leads to metabolic disturbances,
including depletion of the nucleotide pool and kills cells
through a pathway that is related, but not identical to,
thymineless death (44,45). There are two models for the formation of DSBs in cells treated with trimethoprim. First,
Giroux et al. demonstrated recently that the killing of cells
by trimethoprim is linked to maladaptive DNA repair. In
this model, base-excision repair enzymes, acting at sites of
oxidative damage on the chromosome, inadvertently create DSBs when they attempt to repair lesions that are close
to each other (44). Second, a recent study of the thymineless death mechanism (43) revealed that thymine depletion
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Table 1. Strains used in this study
Relevant genotype

MG1655
EAW102
HG356
DE407
RW1568

dinB+

recB::KanR
recB::FRT
lexA3(Ind− )
lexA3(Ind− )

MG1655
MG1655
DE192
MG1655

EAW114
EAW629
EAW669
EAW671

recO::KanR
recF::KanR
recR::KanR
recF::FRT recR::KanR

MG1655
MG1655
MG1655
EAW669

EAW693

recF::FRT recR::FRT recO::KanR

EAW671

EAW287
EAW18
EAW642
EAW633
EAW643
JJC5945
EAW191
EAW282
RW120
RW880

recA(E38K) sulA− ::FRT
dinB::KanR
dnaX-mKate2::KanR
dinB-YPet::KanR
dinB-YPet::FRT dnaX-mKate2::KanR
dnaX-YPet::KanR
umuC-mKate2::KanR
umuC-mKate2::FRT dnaX-YPet::KanR
recA+ sulA− lexA+ umuDC::CmR
umuDC::CmR

MG1655
MG1655
MG1655
MG1655
EAW633
MG1655
MG1655
JJC5945
RW118
MG1655

EAW13
EAW1134

sulA− ::KanR
dinB-YPet::FRT dnaX-mKate2::FRT
sulA− ::KanR
lexA(Def)::CmR
dinB-YPet::FRT dnaX-mKate2::FRT
sulA− ::FRT lexA51(Def)::CmR
dinB-YPet::FRT dnaX-mKate2::FRT
sulA− ::FRT lexA51(Def)::CmR recB::KanR
recA730 srlD300::Tn10
dinB-YPet dnaX-mKate2
sulA− ::KanR lexA51(Def)::CmR
dinB-YPet dnaX-mKate2
sulA::kanR lexA(Def)::CmR recA(E38K)
srlD300::Tn10
dinB(D103N)-YPet
recA730 sulA− ::FRT dinB(D103N)-YPet

MG1655
EAW643

DE406
EAW1141
EAW1144
RW244
RW1594
RW1598
EAW830
AR023
EAW282 sulA−
RW1286
RW546

dnaX+

recB+

Parent strain
lexA+

umuC-mKate2::FRT dnaX-YPet::FRT
sulA− ::KanR
umuC-mKate2::FRT dnaX-YPet::FRT
sulA− ::KanR lexA51(Def)::CmR
recA+ sulA− lexA51(Def) umuDC::CmR

RW1598 was made by P1 transduction of recA730
srlD300::Tn10 from RW244 (52) into RW1594, selecting for
TetR. Colonies were then screened for constitutive UmuD
cleavage using Western blotting, using materials and methods described previously (53). recA and srlD are approximately 90% linked.
AR023 was made by P1 transduction of dinB(D103N)YPet::kanR from EAW830 (30) into EAW287 ((50),
recA[E38K]::FRT[kanS ]), selecting for kanamycin resistance.
RW1286 is E. coli MG1655 umuC-mKate2 dnaX-YPet
sulA− ::kanR lexA51(Def)::CmR and was made in two steps.
First, the wild-type sulA gene of EAW282 (50) was replaced
with sulA− ::kan by P1 transduction from EAW13 (50), to
create EAW282 sulA− . Next, the lexA51(Def) malB::Tn9 allele was transferred from DE406 (51) into EAW282 sulA−
by P1 transduction, selecting for chloramphenicol resis-

DE192
EAW1134
EAW1141
MG1655
RW1588

Source/technique
Published (92)
Lambda Red recombination
EAW102
Published (48)
Transduction of MG1655 with P1 grown on
DE407
Lambda Red recombination
Lambda Red recombination
Lambda Red recombination
Transduction of EAW669 with P1 grown on
EAW629
Transduction of EAW671 with P1 grown on
EAW114
Published (50)
Published (30)
Published (30)
Published (30)
Published (30)
Published (50)
Published (50)
Published (50)
Published (49)
Transduction of MG1655 with P1 grown on
RW120 (49)
Published (50)
Transduction of EAW643 with P1 grown on
EAW13 (46)
Published (51)
Transduction of EAW1134 with P1 grown on
DE406 (51)
Transduction of EAW1141 with P1 grown on
EAW102
Published (52)
Published (30)

RW1594

Transduction of RW1594 with P1 grown on
RW244

MG1655
EAW287

Published (30)
Transduction of EAW287 with P1 grown on
EAW830
Transduction of EAW282 with P1 grown on
EAW13
Transduction of EAW282 sulA− with P1
grown on DE406
Published (93)

EAW282
EAW282 sulA−
RW542

tance. To confirm the presence of the lexA(Def) genotype,
colonies were then screened for high levels of RecA expression by Western blotting with anti-RecA antibodies (54).
The pBAD-MuGam plasmid (pEAW1159) was constructed using a PCR-amplified muGam gene fragment
(us = GGATATCCATATGGCTAAACCAGCAAAACG
TA) consisting of a NdeI site and the beginning of the
muGam gene, and MuGam (ds = GCGAATTCTTAAAT
ACCGGCTTCCTGTTCA consisting of an EcoRI site and
the end of the muGam gene) from EAW727 (MG1655
Founder (55) e14 with chromosomal muGam-gfp in the
attTn7 site). EAW727 was constructed by transducing
muGam-gfp into Founder e14 using a P1 lysate grown on
SMR14350 (56). The PCR product was digested with NdeI
and EcoRI and inserted into pBAD NdeI which was cut
with the same enzymes. pBAD NdeI is pBAD/Myc-HisA
(Invitrogen) that has been mutated to add a NdeI site in
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Table 2. Plasmids used in this study
Description

pEAW1159
pEAW1162
pSTB-sodA-gfp

pBAD derivative expressing MuGam
pBAD derivative expressing MuGam-PAmCherry fusion
pQBI63 derivative expressing superfolder GFP from the SoxS/Fur-regulated sodA
promoter
pQBI63 derivative expressing superfolder GFP from the OxyR-regulated ahpC
promoter
pQBI63 derivative expressing superfolder GFP from the Fur-regulated fepD
promoter
pUA139 derivative expressing GFP from the SOS-regulated sulA promoter
pBAD derivative expressing PAmCherry fusion of mCI, a probe derived from the cI
protein from bacteriophage 
Plasmid expressing FLP recombinase
Plasmid expressing UmuD and UmuC

pCJH0008
pCJH0009
pUA139-PsulA -gfp
pBAD-PAmCherry-mcI
pLH29
pRW154

place of the original NcoI site. All other NdeI sites were
filled in before the mutagenesis. The resulting plasmid was
directly sequenced to confirm presence of wild-type muGam
gene
The pBAD-MuGam-PAmCherry vector (pEAW1162)
was constructed by using two PCR fragments: (i) NdeIMuGam-linker-EcoRI generated from pEAW1159
using the following PCR primers: MuGam us =
GGATATCCATATGGCTAAACCAGCAAAACGTA
consisting of a NdeI site and the beginning of
the muGam gene, and MuGam ds no stop link =
GGATATCGAATTCGCCAGAACCAGCAGCGG
AGCCAGCGGAAATACCGGCTTCCTGTTC AAATG
consisting of an EcoRI site, an 11aa linker, and the
end of the muGam gene without a stop codon. The
PCR product was digested with NdeI and EcoRI.
(ii) EcoRI-PAmCherry- HindIII generated from pBADPAmCherry-mCI (57) using the following PCR primers
PAmCherry usEco = GGATATCGAATTCATGGTGA
GCAAGGGCGAGGAG consisting of an EcoRI site and
the beginning of mCherry, and PAmCherry dsHind =
GGATATCAAGCTTTTACTTGTACAGCTCGTCCAT
consisting of a HindIII site and the end of the mCherry
gene. The PCR product was digested with EcoRI and
HindIII. Both PCR products were ligated to pBAD NdeI
that had been digested with NdeI and HindIII. The resulting plasmid was directly sequenced to confirm the presence
of muGam-PAmCherry.
ROS reporter fusions construction
Three promoters of genes regulated by changes in ROS or
iron levels were cloned upstream of the sf-gfp gene (58) in
a pQBI63 plasmid (Qbiogene). Briefly, upstream regions of
sodA gene (consisting of the 284 nt intergenic region of rhaT
and sodA) regulated by soxS and Fur (59,60), or ahpC gene
(−372 to −1 nt of ATG) regulated by OxyR (59,61–62),
or fepD gene (−170 to −1 nt of ATG) regulated by Fur
(63), were amplified and cloned into the pQBI63 plasmid using BglII/NheI restriction enzymes to generate respectively
pSTB-sodA- gfp, pCJH0008 and pCJH0009. All constructions were confirmed by sequencing.
DNA damaging agent sensitivity assay
Cells were grown overnight in EZ rich defined medium
(Teknova) that contained 0.2% w/v glucose medium (EZ

Source
This study
This study
This study
This study
This study
(80)
(57)
(46)
(49)

glucose) at 37◦ C. The next day, a dilution 1/1000 of each
culture was grown in EZ glucose (at 37◦ C, 150 rpm) until reaching mid log phase (OD600 = 0.3). Six aliquots of
300 l of each culture were transferred into 24-well microplates. The first aliquot was used as control of no treatment, 2% dimethyl sulfoxide (DMSO, 282 mM, 0.2 × MIC
(43)), 30 ng/ml ciprofloxacin, 30 ng/ml ciprofloxacin + 2%
DMSO, 1 g/ml trimethoprim or 1 g/ml trimethoprim
+ 2% DMSO were added in the others. Samples of 150 l
were taken at 0 and 60 min; samples at 0 h were taken just
before treatment. Each sample was serial diluted in PBS by
factor 10 down to 10−6 and dilutions 10−1 to 10−6 were spotted on fresh LB plates (Difco brand). Plates were incubated
overnight at 37◦ C in the dark.
Survival assay following MuGam-PAmCherry expression
To test the effect of MuGam-PAmCherry expression levels on lethality following ciprofloxacin and trimethoprim
exposure, seven cell cultures were set up, expressing different levels of MuGam-PAmCherry from a pBAD plasmid. Cells cultures 1–7 (each 1 ml) were grown in EZ rich
defined medium (Teknova) that contained 0.2% w/v glycerol medium (EZ glycerol) in the presence of ampicillin
(100 g/ml) and different concentrations of L-arabinose
(0, 0.001, 0.003, 0.01, 0.03, 0.1%). Cell culture 8 (1 ml)
was grown EZ glucose medium in the presence of ampicillin (100 g/ml) overnight at 37◦ C, 950 rpm. The next
day, a 1/1000 dilution of each culture (final volume of 1.5
ml) was grown under the same conditions as over-night
growth for 3 h. Each culture was split in three and no
drug, 30 ng/ml ciprofloxacin or 1 g/ml trimethoprim was
added. These cultures were grown (at 37◦ C, 950 rpm) for 2
h. Then, cultures were spun down (5 min; 5000 × g) and
cell pellets were resuspended in 0.5 ml corresponding EZ
medium. Centrifugation and resuspension was carried out
a total of three times. Each cell culture was serial diluted
in PBS by factor ten down to 10−5 and dilutions 10−1 to
10−5 were spotted on fresh LB plates containing 100 g/ml
ampicillin (Difco brand). Plates were incubated overnight at
37◦ C in the dark. For each condition, biological triplicates
were performed. From these experiments, an L-arabinose
concentration of 0.003% was chosen for fluorescence microscopy experiments because this L-arabinose concentration showed no drastic decrease in survival compared to the
sample grown in the presence of glucose.
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Plate reader assay
◦

Fluorescence microscopy
Measurements were recorded on three microscope setups.
Most of the imaging was conducted on an inverted microscope (IX-81, Olympus with a 1.49 NA 100× objective) in an epifluorescence configuration (50). Continuous
excitation was provided using semidiode lasers (Sapphire
LP, Coherent) of the wavelength 514 nm (150 mW max.
output) and 568 nm (200 mW max. output).  -mKate2 in
EAW643 and UmuC-mKate2 in EAW282 were imaged using yellow excitation light (λ = 568 nm) at high intensity
(2750 W cm−2 ), collecting emitted light between 610–680
nm (ET 645/75m filter, Chroma) on a 512 × 512 pixel EMCCD camera (C9100-13, Hamamatsu). Images of UmuCmKate2 in RW1286 were recorded at 275 W cm-2 . For
DinB-YPet imaging of EAW643 time-lapse experiments, we
used green excitation (λ = 514 nm) at 160 W cm−2 collecting light emitted between 525–555 nm (ET540/30m filter, Chroma). For DinB-YPet imaging of RW1594, RW1598
and EAW643 burst acquisitions, cells were imaged at 51 W
cm−2 .  -YPet imaging (EAW282, RW1286) was performed
at 51 Wcm−2 . Cells carrying the SOS reporter plasmid
pUA139-PsulA -gfp were imaged at 16 W cm−2 . Data comparing SOS induction in wild-type, recB and lexA(Ind− )
backgrounds, as well as data comparing DinB-YPet and
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Cells were grown in EZ glucose medium overnight at 37 C.
The next day, a dilution 1:100 of each culture was grown
in EZ glucose (at 37◦ C, 950 rpm) for 3 h. These cultures
were diluted to 1/200. Then, 10 l of these diluted cultures
were added to a total volume of 200 l medium in each well
of a 96-well plate. These 200 l of media contained antibiotic, or hydrogen peroxide, and/or ROS mitigators (final
concentration: 5, 10, 20 and 40 ng/ml ± 2% DMSO or ±
0.35 mM 2,2 -bipyridyl [BiP]; 0.1, 0.3, 1 and 3 g/ml ± 2%
DMSO or ± 0.35 mM BiP; 30, 100, 300 and 500 mM hydrogen peroxide [H2 O2 ] ± 2% DMSO). For experiments with
antibiotics and/or ROS mitigators, antibiotics and/or ROS
mitigators were added just prior to the cells being added.
For experiments with hydrogen peroxide, hydrogen peroxide
was added immediately after the cells were added. For each
well, absorbance (OD600 ) and fluorescence (λexcitation = 470
± 15 nm, λemission = 515 ± 20 nm) were measured every 30
min over 17 h. For cells carrying pUA139-PsulA -gfp, experiments were carried out in 96-well plates from Nalge Nunc
International (no. 265301). For cells carrying pSTB-sodAgfp, pCJH0008 or pCJH0009, experiments were carried out
in 96-well plates from Thermo Scientific (no. 165305). The
experiments were carried out using the CLARIOstar plate
reader (BMG Labtech; settings: orbital reading 4 mm (for
96-well plates from Nalge Nunc International) or 2 mm (for
96-well plates from Thermo Scientific), orbital shaking at
200 rpm, at 37 ◦ C).
Cell cultures were also serial diluted and plated on LB
agar plates in order to calculate the number of cells added to
each well. To each well, when adding wild-type or recFOR
cells, 105 –106 cells were added at the beginning of the experiment. For experiments when adding recB cells, 105 cells
were added at the beginning of the experiment.

DinB(D103N)-YPet foci in the recA(E38K) background,
were recorded on a Nikon Eclipse Ti2 microscope equipped
with a 1.49 NA 100 × objective, using the same excitation
optics and camera described above.
For experiments involving MuGam-PAmCherry, imaging was conducted on an inverted microscope (Nikon
Eclipse-Ti), equipped with a 1.49 NA 100 × objective and a
512 × 512 pixel Photometrics Evolve CCD camera (Photometrics, AZ, US). NIS-Elements equipped with JOBS module was used to operate the microscope (Nikon, Japan).
Continuous excitation is provided using semidiode lasers of
the wavelength 405 nm (OBIS, Coherent, 200 mW max. output), 514 nm (Sapphire LP, Coherent, 150 mW max. output) and 568 nm (Sapphire LP, Coherent, 200 mW max.
output). MuGam-PAmCherry was imaged by simultaneous
illumination with the activation laser 405 nm (1–5 W cm−2 )
and 568 nm readout laser (540 W cm−2 ), a PALM (photoactivation localization microscopy) acquisition protocol,
collecting emitted light from 590 nm (ET590LP, Chroma).
DinB-YPet was imaged using green excitation (λ = 514
nm) at lower power (∼2200 W cm−2 ), collecting light emitted between 535–550 nm (ET535/30m filter, Chroma). NISElements equipped with JOBS module was used to operate
the microscope (Nikon, Japan).
Two-color time-lapse movies were recorded to visualize if
DinB-YPet foci overlap with  -mKate2 foci (EAW643). Sets
of three images were recorded (bright-field [34 ms exposure],
mKate2 fluorescence [100 ms exposure], YPet fluorescence
[50 ms exposure]) at an interval of 10 min for 3 h. To measure colocalization between UmuC-mKate2 with the replisome marker  -YPet (EAW282), we recorded time-lapse
movies at the same intervals but different exposures for the
replisome marker (bright-field [34 ms exposure], mKate2
fluorescence [100 ms exposure], YPet fluorescence [500 ms
exposure]).
Burst acquisitions of DinB-YPet (movies of 300 × 50
ms frames taken every 100 ms light at 514 nm) were collected, subsequently to each burst acquisition, an image
of  -mKate2 (568 nm) was taken (imaging sequence for
RW1594) and a bright-field image (34 ms exposure). With
this imaging sequence, we determined the number of DinBYPet foci per cell in Figures 4 and 5. RW1286 was imaged similarly (Figure 6); we recorded burst acquisitions of
UmuC-mKate2 (568 nm) followed by a snapshot of  -YPet
(514 nm). All images were analyzed with ImageJ (64).
The MuGam-PAmCherry imaging acquisition was
recorded as a set of two acquisitions (bright-field image
[100 ms exposure], PAmCherry fluorescence [simultaneous
illumination with the activation laser 405 and 568 nm
readout laser for 200 frames each with 100 ms exposure]).
This protocol was only executed once for a field-of-view
to minimize laser damage. Consequently, before and after
antibiotic treatment shows a new set of cells. Images taken
after antibiotic addition were recorded following 2 h of
antibiotic treatment.
Time-sampling of DinB-YPet and PAmCherry-mCI expressing cells were performed as follows: sets of three acquisitions were recorded (bright-field [100 ms exposure], YPet
fluorescence [50 ms exposure]; PAmCherry fluorescence [simultaneous illumination with the activation laser 405 and
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568 nm readout laser for 200 frames each with 100 ms exposure]). This protocol was only executed once for a fieldof-view to minimize laser damage. Consequently, each time
point shows a new set of cells. The experiment was conducted over 3 h, an image was taken every 5 min.
Flow cell designs

Preparation of cell cultures for microscopy
To minimize background fluorescence in cells, strains
were first cultured overnight in EZ rich defined medium
(Teknova), then sub-cultured by diluting the overnight
culture 1:1000 in fresh EZ rich defined medium and incubating for ∼3 h prior to imaging. With the exception of cells carrying the MuGam-PAmCherry plasmid
pEAW1162, all strains were grown at 37◦ C in EZ glucose. All strains containing a KanR cassette were grown
in the presence of kanamycin (20 g/ml). Cells carrying
pEAW1162 were grown at 37◦ C in EZ glycerol containing
0.001% L-arabinose and ampicillin (100 g/ml). Cultures
used for imaging under ROS-mitigating conditions were
grown in the presence of the particular mitigator used for
the experiment during the sub-culturing step; DMSO (2%
v/v, 282 mM, 0.2 × MIC (43)) or BiP (0.35 mM, 0.5 × MIC
(43)).
Imaging in flow cells
Cells were loaded into flow cells, allowed a few minutes to
associate with the APTES surface, then loosely associated
cells were removed by pulling through fresh medium. The
experiment was then initiated by adding either an antibiotic alone or in combination with DMSO to the medium

Analysis of cell filamentation, concentrations, SOS induction
level and number of foci
We selected single cells to obtain information about SOS
induction, DinB and UmuC levels upon UV irradiation
(>100 cells for every time point). MicrobeTracker 0.937
(65), a MATLAB script, was used to create cell outlines
as regions of interest (ROI). We manually curated cell outlines designated by MicrobeTracker at t = 0 min (time point
of antibiotic addition) and at 30 min time intervals until 180 min. By curating cell outlines manually, we ensure
accuracy and purely select non-overlapping, in-focus cells
for analysis. These ROI were imported in ImageJ 1.50i.
The cell outlines were then used to measure mean cell intensities, cell lengths and the number of foci per cell. Parameters describing foci (number, positions and intensities)
were obtained using a Peak Fitter plug-in, described previously (30,50). Prior to determining DinB-YPet foci UmuCmKate2 per cell from burst acquisition movies in lexA(Def),
average projections in time were curated from frame 1 to
101 (10 × 100 ms = 1 s). Prior to determining MuGamPAmCherry or PAmCherry-mCI foci per cell from burst
acquisition movies, maximum projections in time were curated over the entire movie, capturing all binding events of
MuGam-PAmCherry.
Using information of mean cell brightness derived from
DinB-YPet expressing cells, we also calculated DinB-YPet
concentrations of cells grown in the absence or presence of
antibiotic. In a previous study (30), we calculated the DinBYPet concentration which correlates with a certain mean
cell brightness (in the absence of ciprofloxacin: 6 ± 1 nm
[SEM]; 180 min after ciprofloxacin treatment: 34 ± 3 nM
[SEM]). We utilized these values to calculate the DinB-YPet
concentration for ciprofloxacin ± DMSO or trimethoprim
± DMSO treated cells.
Analysis of colocalization events
Foci were classed as colocalized if their centroid positions
(determined using our peak fitter tool) fell within 2.18 px
(218 nm) of each other. When treating with ciprofloxacin,
we determined that for DinB-YPet– -mKate2 localization
the background of DinB foci expected to colocalize with
replisomes purely by chance is ∼4% at 180 min. This was
calculated by taking the area of each cell occupied by replisome foci (including the colocalization search radius) and
dividing by the total area of the cell. The value of 4% corresponds to the mean of measurements made over 121 cells.
Since the foci density of replisomes stays fairly constant
following ciprofloxacin treatment, the chance colocalization of DinB-YPet foci with  -mKate2 is ∼4% during the
experiment (30). Chance colocalization of  -mKate2 with
DinB-YPet is however not constant over time because most
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All imaging experiments were carried out in home-built
quartz-based flow cells. These flow cells were assembled
from a no. 1.5 coverslip (Marienfeld, REF 0102222, for
imaging on IX-81, Olympus) or (Marienfeld, REF 0107222,
for imaging on Nikon Eclipse-Ti), a quartz top piece (45 ×
20 × 1 mm) and PE-60 tubing (Instech Laboratories, Inc.).
Prior to flow-cell assembly, coverslips were silanized with
(3-aminopropyl)triethoxysilane (APTES, from Alfa Aeser).
First, coverslips were sonicated for 30 min in a 5M KOH
solution to clean and activate the surface. The cleaned coverslips were rinsed thoroughly with MilliQ water and then
treated with a 5% (v/v) solution of APTES in MilliQ water.
The coverslips were subsequently rinsed with ethanol and
sonicated in ethanol for 20 seconds. Afterward, the coverslips were rinsed with MilliQ water and dried in a jet of N2 .
Silanized slides were stored under vacuum prior to use.
To assemble each flow cell, polyethylene tubing (BTPE60, Instech Laboratories, Inc.) was glued (BONDiT B-482,
Reltek LLC) into two holes that were drilled into a quartz
piece. After the glue solidified overnight, double-sided adhesive tape was stuck on two opposite sides of the quartz
piece to create a channel. Then, the quartz piece was stuck
to an APTES-treated coverslip. The edges were sealed with
epoxy glue (5 Minute Epoxy, PARFIX). Each flow cell was
stored in a desiccator under mild vacuum while the glue
dried. Typical channel dimensions were 45 × 5 × 0.1 mm
(length × width × height).

(30 ng/ ml ciprofloxacin, 30 ng/ ml ciprofloxacin with 2%
(v/v) DMSO, 1 g/ml trimethoprim, 1 g/ml trimethoprim with 2% (v/v) DMSO or 1 g/ml trimethoprim with
0.35 mM BiP). Throughout the experiment, medium was
pulled through the flow cell using a syringe pump, at a rate
of 50 l/min. For each condition, triplicate measurements
were recorded.

8496 Nucleic Acids Research, 2020, Vol. 48, No. 15

Proteins
The wild-type E. coli RecA protein was purified using
strains and protocols described by Craig and Roberts (66).
The RecA concentration was determined using the extinction coefficient ε 280 = 2.23 × 104 M−1 cm−1 (66).
The E. coli RecA(E38K) protein was purified as previously described (67) with the following modifications. After washing the protein pellet with R buffer plus 2.1 M
ammonium sulfate, the pellet was resuspended in R buffer
plus 1 M ammonium sulfate. The sample was loaded onto
a butyl-Sepharose column and washed with 1.5 column
volumes of R buffer plus 1 M ammonium sulfate. It was
then eluted with a linear gradient from R buffer plus 1
M ammonium sulfate to R buffer, carried out over five
column volumes. Peak fractions were identified by sodium
dodecyl sulphate-polyacrylamide gelelectrophoresis (SDSPAGE) analysis and pooled. The protein was loaded onto
a hydroxyapatite column as done previously, but with the
linear gradient from 10–500 mM P buffer. The fractions
were dialyzed against R buffer plus 50 mM KCL and 1 mM
dithiothreitol three times. The fractions were loaded onto a
Source 15S column and washed with R buffer plus 50 mM
KCl and 1 mM dithiothreitol until the UV trace receded
from peak. Next, the pool was loaded onto a Source 15Q
column and eluted with a linear gradient from 0.05–1 M
KCl over 25 column volumes. Peak fractions were identified as above and pooled. A DEAE-Sepharose column was
not used. Protein in this pool was precipitated by the addition of equal volume of 90% saturated ammonium sulfate. The precipitate was stirred and then spun down at 13
000 rpm for 30 min. The pellet was resuspended in R buffer
plus 1 M ammonium sulfate, stirred for an hour, and then
spun down again. This protein was loaded onto a butylSepharose column and eluted in a gradient from R buffer
and 1 M ammonium sulfate to R buffer. The fractions were
identified, pooled, and concentrated using GE Vivispin 20

10K MWCO centrifuge filter concentrating units. The protein was flash frozen in liquid nitrogen and stored at −80◦ C.
The concentration was determined as above. No exonuclease or other endonuclease activities were detected.
Pol IV (dinB) coding sequence was cloned into NcoI and
BamHI sites of pET16b to generate a native pol IV expression construct. E. coli strain Tuner/pLysS (Novagen) carrying the expression construct was grown in LB medium supplemented with 20 g/ml chloramphenicol and 100 g ml–
1 ampicillin. Expression of pol IV was induced by adding
IPTG to 1 mM and growing for 3–4 h at 30◦ C. Collected
cells (∼20 g) were resuspended in 50 mL of lysis buffer
(50 mM Tris–HCl, pH 7.5, 1 M NaCl, 10% sucrose, 2
mM dithiothreitol, 1 mM ethylenediaminetetraacetic acid
(EDTA) and protease inhibitor cocktail). Cells were lysed
by lysozyme (2 mg/ml) and the clarified extract was collected following centrifugation at 15 000 × g for 30 min.
Pol IV was then precipitated by ammonium sulfate added to
30% saturation and stirring for 10 min. The precipitate was
subjected to gel-filtration in GF-buffer (20 mM Tris–HCl,
pH 7.5, 1 M NaCl, 0.1 mM EDTA, 1 mM dithiothreitol)
using a GE Healthcare Superdex-75 XK-26/60 gel filtration
column. Pol IV fractions were pooled, dialyzed overnight in
PC-buffer (20 mM Tris–HCl, pH 7.5, 0.1 mM EDTA 1 mM
dithiothreitol, 10% glycerol), containing 200 mM NaCl and
then subjected to phosphocellulose chromatography (P-11,
Whatman). After washing extensively with PC-buffer + 200
mM NaCl, pol IV was eluted with a linear gradient of 200–
500 mM NaCl. Fractions containing native pol IV (>99%
pure) were pooled and stored at −70◦ C.
Surface plasmon resonance (SPR) experiments
Surface plasmon resonance (SPR) experiments were conducted on BIAcore T200 instrument (GE Healthcare) using
streptavidin (SA) coated sensor chips, probing the formation of RecA structures (assembled from RecA[E38K]) on
ssDNA and dsDNA. Experiments were carried out at 20◦ C
at a flow rate of 5 l min−1 . As described previously (57),
SA chips were activated and stabilized, single-stranded biotinylated 71-mer poly-dT oligonucleotide bio-(dT)71 was
immobilized, followed by RecA(E38K) filament assembly.
RecA(E38K) filaments were assembled on bio-(dT)71 by injecting 1 M RecA(E38K) in SPRRecA(E38K) buffer (20mM
Tris–HCl, pH 8.0, 10 mM KCl, 10 mM MgCl2, 0.005%
surfactant P20 and 0.5 mM dithiothreitol) supplemented
with 1 mM adenosine 5 -(␥ -thio) triphosphate (ATP␥ S)
at 10 l min−1 for 400 s. Similarly, biotinylated dsDNA
was immobilized (as previously described (57)), followed
by RecA(E38K) filament assembly. RecA(E38K) filaments
were assembled on dsDNA (sequence: 5 -TCC TTT CGT
CTT CAA AGT TCT AGA CTC GAG GAA TTC TAA
AGA TCT TTG ACA GCT AGC CAG-3 , 5 end is biotinylated) by injecting 1 M RecA(E38K) in SPRRecA(E38K)
buffer (20 mM Tris–HCl, pH 8.0, 10 mM KCl, 10 mM
MgCl2, 0.005% surfactant P20 and 0.5 mM dithiothreitol)
supplemented with 0.5 mM ATP␥ S at 5 l min−1 for 500
s. Then, SPRRecA(E38K) supplemented with 0.5 or 1 mM
ATP␥ S buffer was flowed in at 5 l min−1 for 2500 s, in
order to stabilize the formed filaments. From 3000 s, 1 M
RecA(E38K) in SPRRecA(E38K) buffer supplemented with 0.5
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cells contain no pol IV foci in the absence of any DNA
damage. Chance colocalization is close to zero at 0 min; at
60 min, chance colocalization is ∼5%; at 120 min, chance
colocalization is ∼3%. Moreover, chance colocalization of
 -mKate2 with DinB-YPet is overall reduced under ROSmitigating conditions due to a reduced number of foci per
cell (chance colocalization close to zero at 0 min; at 120 min,
∼2%). Chance colocalization of  -mKate2 with DinB-YPet
in trimethoprim-treated cells amounts to ∼1% from 60–90
min (close to zero before 60 min). Under ROS-mitigating
conditions, chance colocalization is always close to zero because both the mean cell size and the number of pol IV foci
per cell do not increase post treatment (see Supplementary
Materials).
The chance colocalization of UmuC-mKate2 with  YPet is similar to the chance colocalization of DinB-YPet
with  -mKate2 (chance colocalization: ∼4%). The expected
colocalization of  -YPet with UmuC-mKate2 by background is close to zero until 90 min as UmuC-mKate2 is
neither upregulated nor released from the membrane (see
‘Results’ section). Chance colocalization is ∼3% at 180 min
after ciprofloxacin treatment and ∼2% after the combinational treatment of ciprofloxacin/DMSO.
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DNA substrates for ATPase and LexA cleavage assay
M13mp18 cssDNA was purified as previously described
(68), and M13mp18 cdsDNA was prepared as previously
described (68–70). The M13mp18 nicked dsDNA was prepared by nicking with DNaseI according to manufacturer’s
recommendations. All DNA concentrations are given in
terms of total nucleotides.
ATPase assay
Adenosinetriphosphate (ATP) hydrolysis of wild-type
RecA and RecA(E38K) on nicked cdsDNA was measured
using a spectrophotometric enzyme assay (71,72). ATP
regeneration from phosphoenolpyruvate and ADP was
coupled to the oxidation of NADH, which was monitored
by the decrease in absorbance of NADH at 380 nm. A
total of 380-nm light was used so that the signal remained
within the linear range of the spectrophotometer during
the experiment. The assays were carried out on a Varian
Cary 300 dual beam spectrophotometer equipped with
a temperature controller and a 12-position cell changer.
The cell path length and band pass were 0.5 and 2 nm,
respectively. The NADH extinction coefficient at 380 nm
of 1.21 mM−1 cm−1 was used to calculate the rate of ATP
hydrolysis.
The reactions were carried out at 37◦ C in a buffer containing 25 mM Tris-Ac (80% cation, pH 7.5), 3 mM potassium glutamate, 10 mM magnesium acetate, 5% (w/v) glycerol, 1mM dithiothreitol, an ATP regeneration system (10
units/ml pyruvate kinase, 3 mM phosphoenolpyruvate) and
a coupling system (2 mM NADH and 10 units/ml lactate
dehydrogenase). The concentration of DNA (pEAW951
nicked cdsDNA) was 5 M. One cuvette was a blank control that contained everything except the DNA (volume
compensated with TE). The nicked cdsDNA, buffer, and
ATP regeneration system were preincubated at 37◦ C for 10
min before addition of 3 mM ATP and 3 M wild-type
RecA or RecA(E38K). The process of data collection was
then started.

LexA cleavage assay
The cleavage of LexA was performed essentially as previously described (73). Reaction mixtures (125 l) contained 40 mM Tris–HCl, pH 8.0, 10 mM MgCl2 , 30 mM
NaCl, 2 mM dithiothreitol, 3 M of M13mp18 circular
single-stranded DNA or pEAW951 nicked circular doublestranded DNA, 3 mM ATP␥ S, LexA and RecA as noted.
Reactions were incubated at 37◦ C for 10 min before addition of LexA. The reaction products were separated and visualized by 15% SDS-PAGE stained with Coomassie blue.
Western blotting
To analyze the cleavage of UmuD in cells treated with
antibiotics, SOS-normal (RW120) and SOS-constitutive
(RW546) strains were transformed with pRW154, which
expresses the UmuD and UmuC proteins from their native promoter (49). Overnight E. coli LB cultures of
RW120/pRW154 and RW546/pRW154 were diluted 1–100
in fresh LB with appropriate antibiotics and grown to
mid-log (∼OD 0.5, ∼3 h). Aliquots were then taken for
the untreated samples. Either ciprofloxacin (30 ng/ml) or
trimethoprim (1 g/ml) was added to the remaining culture and incubated with or without the addition of 2%
DMSO. Samples were taken at 1, 2 and 3 h. Whole cell
extracts were made by centrifuging 1.5 ml of culture and
adding 90 l of sterile deionized water and 30 l of NuPAGE LDS sample buffer (4×) (Novex, Life Technologies)
to the cell pellet. Five cycles of freeze/thaw on dry ice and
in a 37◦ C water bath were performed to lyse the cells. Extracts were boiled for 5 min prior to loading. Samples were
run on NuPAGE 4–12% Bis-Tris gels (Novex Life Technologies) and transferred to Invitrolon PVDF (0.45 m pore
size) membranes (Novex Life Technologies). Membranes
were incubated with anti-UmuD antibodies (54) (1:5000
dilution) at room temperature overnight. Then the membranes were incubated with goat anti-rabbit IgG (H+L)
alkaline phosphatase conjugate (1:10 000 dilution) (BIORAD). Subsequently, the membranes were treated with
the CDP-Star substrate (Tropix). Membranes were then
exposed to BioMax XAR film (Carestream) to visualize
UmuD protein bands.
RESULTS
Induction of DNA double-strand breaks by ciprofloxacin and
trimethoprim
We first investigated how many DSBs are created following ciprofloxacin and trimethoprim treatment. We imaged
cells expressing a fluorescent fusion of the DSB reporter
MuGam (56) to the photoactivatable mCherry protein
(PAmCherry1 (57)). The data collection strategy is summarized in Supplementary Figure S1. MuGam-PAmCherry
was expressed from pBAD-derived plasmid pEAW1162,
which was introduced into the MG1655 wild-type E. coli
background. For these single-molecule microscopy experiments, cells were grown in medium containing 0.003% Larabinose. These conditions supported MuGam expression
levels that had minimal effects on survival upon drug treatment (Supplementary Figure S2A) and yielded satisfactory
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mM ATP␥ S was injected at a flow rate of 5 l min−1 for
4200 s.
Pol IV association with RecA(E38K)-dsDNA filaments
was observed by injecting 0.65 M pol IV in SPRRecA(E38K)
buffer supplemented with 0.5 mM ATP␥ S for 220 s at 5 l
min−1 , monitoring pol IV association. From 220 s, buffer
containing 0.5 mM ATP␥ S was flowed in at 5 l min−1
and fast dissociation of pol IV was observed. Similarly, pol
IV association with dsDNA was monitored, giving a lower
response curve. We also observed non-specific binding of
pol IV to the chip surface, making it impossible to measure
binding kinetics of pol IV.
The surface was regenerated as previously reported (57).
Furthermore, the SPR signal was corrected using a flow cell
without immobilized bio-(dT)71 or dsDNA and corrected
for the amount of immobilized RecA(E38K) (57). Ghodke
et al. utilized this assay to monitor the binding kinetics of
mCI, a probe derived from the bacteriophage  repressor
CI, at RecA-ssDNA filaments (57).
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MuGam-PAmCherry signals for imaging (Supplementary
Figure S2B).
In the absence of antibiotic, cells exhibited 0.3 ± 0.1
MuGam foci per cell (Figure 1A and B) with most cells
(74%) containing no foci (Figure 1C). Trimethoprim treatment for 2 h (1 g/ml trimethoprim) led to a distinct increase in MuGam foci (1.9 ± 0.1 foci per cell Figure 1B)
with 78% of cells now containing foci (Figure 1C). These
results are consistent with earlier reports that trimethoprim
treatment can induce the formation of DSBs (44). Following ciprofloxacin treatment (30 ng/ml ciprofloxacin), cells
contained even more MuGam foci (4.9 ± 0.3 foci per cell,
Figure 1B) with 98% of cells containing foci (Figure 1C).
Thus, the analysis indicated that both the trimethoprim and
ciprofloxacin treatments promoted the formation of DSBs,
with ciprofloxacin treatment inducing approximately 2.5fold more DSBs than trimethoprim. Ciprofloxacin-induced
DSBs have also been reported by Pribis et al. (39), using a
similar MuGam reporter.
DSB formation in trimethoprim-treated cells is dependent on the intracellular production of ROS (44). Consistent with this, we observed that co-treatment of cells with

DSB resection is the primary SOS response trigger in
ciprofloxacin- and trimethoprim-treated cells
Damage-induced upregulation of pol IV expression is facilitated by the SOS response (reviewed in (76)). SOS is triggered by the presence of RecA* nucleoprotein filaments,
which form on regions of ssDNA (77). RecA* filaments
formed on ssDNA gaps and end-resected DSBs both act as
SOS triggers (78). Both trimethoprim and ciprofloxacin are
known to induce the SOS response (39,79). Following treatment with each drug, we investigated the degree to which induction of the SOS response depends on DSB repair via the
RecBCD pathway, and thus the level of SOS-induced pol
IV upregulation. We repeated the time-lapse experiments on
cells that carried an SOS-reporter plasmid, in which GFP is
expressed from the SOS-inducible sulA promoter (pUA139PsulA -gfp; fast-folding GFP, gfpmut2 (80)).
In the absence of any antibiotic treatment, cells exhibited
very low fluorescence, consistent with the repression of the
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Figure 1. Number of MuGam-PAmCherry foci per cell following
ciprofloxacin or trimethoprim treatment. Escherichia coli MG1655 cells
carrying plasmid pEAW1162 were imaged on a single-molecule sensitive fluorescence microscope. (A) Fluorescence signal from MuGamPAmCherry at 0.003% L-arabinose: maximum intensity projections over
200 × 100 ms frames showing MuGam-PAmCherry foci. From left to
right: MuGam signal with no antibiotic, 2 h treatment with 1 g/ml
trimethoprim, 2 h treatment with 30 ng/ml ciprofloxacin. (B) Mean number of MuGam foci per cell. Cells were left untreated (n = 140), treated with
1 g/ml trimethoprim (n = 138), or treated with 30 ng/ml ciprofloxacin
(n = 125). The error bars represent standard error of the mean over the
number of cells. * for P < 0.05; ** for P < 0.01 in two-sample t-test for differences of means. (C) Percentage of cells containing MuGam foci: 0 foci
(light gray), 1 focus (gray), 2–4 foci (amber) and >4 foci (red). Cells were
left untreated (n = 140), treated with 1 g/ml trimethoprim (n = 138), or
treated with 30 ng/ml ciprofloxacin (n = 125).

the ROS-mitigating compound DMSO (74) reduced the activities of ROS-induced promoters (Supplementary Figures
S3–5) and reduced DSB formation (Supplementary Figure
S6) in response to trimethoprim exposure.
It was recently demonstrated that the killing of bacterial
cells by ciprofloxacin is also strongly dependent on intracellular ROS production (42). We found that co-treatment with
DMSO suppressed a significant portion of ciprofloxacininduced DSBs (Supplementary Figure S6). This seemingly
conflicts with conclusions made during two recent studies (39,75). Pribis et al. concluded that mitigation of ROS
did not prevent DSB formation in ciprofloxacin-treated
cells (39). They reported that ∼80% of cells contained
MuGam foci following ciprofloxacin treatment, both in the
absence of ROS mitigators, and in the presence of either
2,2 -bipyridine or thiourea. In a second recent study, which
included analysis of DSB formation in cells treated with another quinolone, nalidixic acid, Hong et al. concluded that
mitigation of ROS did not prevent DSB formation (75). In
that study, DSB formation in cells was monitored using a
fluorescent fusion of the RecN protein, a recombination
mediator that is involved in DSB repair. The authors observed that 1 h after treatment 97% of cells contained foci
in the absence of ROS mitigators, compared with 81% of
cells in the presence of bipyridyl and thiourea. In the current study we observed that very similar proportions of cells
exhibited MuGam foci following ciprofloxacin treatment,
with 98% of cells containing foci in the absence of ROS mitigators and 79% containing foci in the presence of DMSO
(Supplementary Figure S6B). This result is in good agreement with the data presented in the Pribis et al. and Hong
et al. studies. Notably however, we observed that the mean
number of MuGam foci per cell was significantly reduced in
the presence of the ROS-mitigating agent DMSO (2.2 ± 0.2
foci per cell; (Supplementary Figure S6C) compared with
treatment in the absence of ROS mitigators (4.9 ± 0.3 foci
per cell, Figure 1B). The mean number of DSBs per cell was
not reported in either the Pribis et al. or Hong et al. studies.
We conclude that fewer DSBs are formed in ciprofloxacintreated cells when the damaging effects of ROS are mitigated with DMSO.
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Figure 2. PsulA -gfp expression levels (SOS response levels) following ciprofloxacin or trimethoprim treatment is recB-dependent. (A) Left panel: Fluorescence images showing the expression of GFP from an SOS reporter plasmid (pUA139-PsulA -gfp) at 0, 60, 120 and 180 min (left to right) after treatment with
1 g/ml trimethoprim (MG1655 cells), 30 ng/ml ciprofloxacin (MG1655 cells) or 30 ng/ml ciprofloxacin (recB cells; HG356) (top to bottom). Scale bar
represents 5 m. Right panel: Quantitation of GFP expression levels. Mean cell intensity is plotted against time (trimethoprim: light gray line, ciprofloxacin:
dark gray line, ciprofloxacin in recB: red line). In this analysis the precise number of cells included is not determined but is well in excess of 100 cells at each
time point. Gray-shaded error bands represent standard error of the mean. (B) PsulA -gfp expression levels in wild-type (MG1655) and recB cells (HG356).
For each strain, 104 –106 cells were added to each well at the beginning of the experiment. Measurements of absorbance (OD600 ) and fluorescence intensity
(a.u.) were carried out every 30 min over 18 h. Upper row shows absorbance (OD600 ) and bottom row illustrates intensity values/OD600 , consistent with
expression levels. Error bars represent standard error of the mean over three independent biological replicates. First column: Normal growth condition
for wild-type or recB cells (wild-type: dark gray; recB: orange). Second column: ciprofloxacin treatment of wild-type cells (5 ng/ml: black; 10 ng/ml:
gray; 20 ng/ml: blue; 40 ng/ml: orange). Third column: ciprofloxacin treatment of recB cells (same color coding as second column). Fourth column:
trimethoprim treatment of wild-type cells (0.1 g/ml: black; 0.3 g/ml: gray; 1 g/ml: blue; 3 g/ml: orange). Fifth column: trimethoprim treatment of
recB cells (same color coding as fourth column).

sulA promoter in the absence of exogenously applied DNA
damage (Figure 2A, ‘0 min’). Cells exposed to trimethoprim
exhibited clear SOS induction (100-fold increase from 0 to
180 min in the mean cell intensity derived from GFP signal). Cells exhibited even more robust SOS induction upon
treatment with ciprofloxacin as evidenced by the increase in
GFP fluorescence in the 180 min time window after addition of ciprofloxacin (170-fold induction from 0 to 180 min,
Figure 2A). These results were confirmed using plate-reader
assays (Figure 2B; Supplementary Figure S7A and B).
Next, we monitored SOS induction in cells lacking recB
(HG356 [recB] + pUA139-PsulA -gfp) to determine if SOS

induction by ciprofloxacin is dependent on DSB processing.
The deletion of recB strongly inhibited the SOS response
following ciprofloxacin treatment (0.4-fold induction at 180
min in comparison to recB+ , Figure 2A). While recB deletions are known to reduce survival in cells treated with
ciprofloxacin (81), we observed that most cells lacking recB
continued to grow, forming short filaments and occasionally dividing, during the 180 min time-lapse measurement
(Supplementary Figure S8A and Movie S1), indicating
that the lack of SOS induction observed for ciprofloxacintreated recB-deficient cells did not stem from gross inhibition of all cellular functions. Plate-reader assays did not re-
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DNA polymerase IV activity correlates with number of DNA
double-strand breaks
We next monitored changes in intracellular pol IV concentrations and levels of focus formation in antibiotic-treated
cells, using a strain that expressed fluorescently tagged pol
IV (DinB-YPet). Following ciprofloxacin treatment, we further investigated if pol IV colocalizes with RecA* structures, which can form at DSB repair intermediates. Using
two-color imaging, we measured colocalization of fluorescently tagged pol IV with the fluorescently tagged RecA*
probe, mCI (57). In our previous study we demonstrated
that the DinB-YPet allele is functionally active (30). In the
current study, we confirmed that cells expressing fluorescently tagged pol IV exhibited similar sensitivity to both
ciprofloxacin and trimethoprim as wild-type MG1655 cells
(Supplementary Figure S12, first two panels).
Trimethoprim treatment resulted in a clear increase in
DinB-YPet intensity (Figure 3A) and was accompanied by
cell filamentation (Supplementary Figure S13), a hallmark
of the SOS response. 180 min after trimethoprim addition,
the mean cellular fluorescence intensity (a proxy for intra-

cellular DinB-YPet concentration) had increased by more
than four-fold (intensity increase from 135 to 557, Figure
3B). Treatment with ciprofloxacin also led to filamentation
(Supplementary Figure S13) and a significant increase in
DinB-YPet fluorescence intensity (Figure 3A), resulting in
an increase in the intracellular DinB-YPet concentration (7fold increase from 140 to 990 mean cell brightness, Figure
3B). This increase is in line with the results of our previous study, in which we measured an increase in intracellular
DinB-YPet (pol IV) concentrations from 6 ± 1 nM prior to
treatment (standard error of the mean, SE) to 34 ± 3 nM
(SE) 180 min after ciprofloxacin addition (30). Comparing
intensity levels in our current and previous studies, we infer that the intracellular pol IV concentration is ∼23 nM
in trimethoprim-treated cells and 34 nM in ciprofloxacintreated cells. In general, conditions in which a large number
of DSBs were detected yielded high intracellular concentrations of DinB-YPet (compare Figures 1B and 3B, Supplementary Figure S14A). This is consistent with the SOSinduction results described above (Figure 2) and suggests
that DSB processing drives an increase in pol IV production via the SOS response.
Cells exhibit distinct pol IV foci when individual DinBYPet molecules bind to DNA and thus experience decreased diffusional mobility (30,82). Since cells expressing
a fluorescently tagged, catalytically dead mutant of pol IV
do not exhibit foci (30), the foci observed in response to
antibiotic treatment represent pol IV molecules that could
be engaged in catalytic functions. Prior to the addition of
antibiotic, cells contained on average 0.6 ± 0.2 foci per
cell (SE) (Figure 3C). Trimethoprim treatment induced a
slight increase in the number of DinB-YPet foci with 0.9
± 0.2 per cell (SE) at 180 min. Following treatment with
ciprofloxacin, the number of foci steadily increased, and by
180 min, cells exhibited 4.2 ± 1.1 foci per cell. Conditions
in which a large number of DSBs were detected also yielded
a large number of DinB-YPet (compare Figures 1B and 3B;
Supplementary Figure S14B), suggesting that pol IV binding might be involved in DSB repair.
We next determined how frequently pol IV foci colocalized with RecA* structures formed at sites of DSB repair. The MuGam-PAmCherry probe used above to detect DSBs blocks DSB repair (56), thus we could not use
MuGam-PAmCherry to test whether pol IV localized to
DSB repair intermediates. Instead, we visualized the localizations of fluorescent pol IV (DinB-YPet) and a RecA*
marker PAmCherry-mCI; a red fluorescent protein fusion
of a monomeric C-terminal fragment of the  repressor that
retains the ability to bind RecA* in cells (57). We treated
EAW633 (dinB-YPet) cells carrying pBAD-PAmCherrymCI with ciprofloxacin, then carried out live-cell photoactivatable localization microscopy (PALM), collecting the signal of pol IV (DinB-YPet) and mCI foci (PAmCherry-mCI
bound to RecA* structures). We have previously noted that
most of the mCI foci appear at locations distal to the replisome in UV-irradiated cells (57).
Following ciprofloxacin treatment, cells typically contained multiple mCI foci (Figure 3D). At later time points,
some cells contained more elongated ‘bundle’ structures as
described previously (57). We next determined the percentage of DinB-YPet foci that colocalized with mCI foci and

Downloaded from https://academic.oup.com/nar/article/48/15/8490/5873806 by guest on 23 September 2020

veal a sustained increase in cell density for recB deletion
cells following ciprofloxacin treatment (Figure 2B, middle
column), suggesting that the initial growth observed by microscopy stagnates soon after the 180 min observation window. Deletion of recB attenuated GFP levels to the same
extent as observed in cells carrying an SOS-defective allele (RW1568, lexA[Ind− ]), indicating that ciprofloxacininduced SOS is attenuated completely in the recB strain
(Supplementary Figure S8B and C).
Plate-reader assays demonstrated that induction of the
SOS response upon trimethoprim exposure is also highly
dependent on recB (Figure 2B, last column). In contrast,
deletion of the recF, O and R genes (EAW693, recF recO
recR), which are associated with SOS induction via the
ssDNA gap repair pathway, had little impact on SOS induction in both ciprofloxacin- and trimethoprim-treated
cells (Supplementary Figure S9). Beyond this, the inclusion
of ROS mitigators, which reduce the number of MuGam
foci (DSB markers, Supplementary Figure S6), also reduced SOS-induced GFP levels (Supplementary Figures S7
and 10). Measurements within an SOS-constitutive strain
(EAW287, recA[E38K]) confirmed that this reduction in
signal was not caused by DMSO-induced quenching of the
GFP signal (Supplementary Figure S11).
Taken together our measurements indicate that SOS induction levels are strongly dependent on recB-dependent
DSB processing in cells treated with ciprofloxacin or
trimethoprim. The observation that SOS induction depends strongly on recB (Figure 2 or Supplementary Figure S7), but not recF, O and R (Supplementary Figure S9;
(47)), suggests that DSBs are formed frequently under both
ciprofloxacin and trimethoprim conditions and that ssDNA
gaps do not accumulate to appreciable levels or are subsequently converted to DSBs. The reduction of the number
of DSBs (as monitored by counting MuGam-PAmCherry
foci) in the presence of the ROS mitigator is consistent with
the hypothesis that ssDNA gaps are converted to DSBs in
cells.
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Figure 3. Pol IV concentration and focus formation following ciprofloxacin or trimethoprim treatment and pol IV colocalization with RecA* structures.
(A) Fluorescence images showing cells (EAW643) expressing DinB-YPet (Pol IV) at 0, 90 and 180 min (left to right) after trimethoprim (1 g/ml) or
ciprofloxacin (30 ng/ml) treatment (top to bottom). Scale bar represents 5 m. (B) Cellular DinB-YPet intensities during treatment. Mean cell brightness
is plotted against time (1 g/ml trimethoprim: light gray line; 30 ng/ml ciprofloxacin: dark gray line). In this analysis the precise number of cells included
is not determined but is well in excess of 100 cells at each time point. Gray-shaded error bands represent standard error of the mean. (C) Number of
DinB-YPet foci per cell are plotted against time (1 g/ml trimethoprim: light gray line; 30 ng/ml ciprofloxacin: dark gray line). In this analysis, the precise
number of cells included is not determined but is well in excess of 100 cells at each time point. Gray-shaded error bands represent standard error of the
mean. (D and E) Colocalization between DinB and mCI after ciprofloxacin treatment (30 ng/ml) in EAW633 cells transformed with pEAW1162. (D)
Merged images of discoidal filtered DinB-YPet (green) and PAmCherry-mCI (magenta) images at 55, 70, 100 and 155 min after ciprofloxacin addition (30
ng/ml). (E) Colocalization percentages after ciprofloxacin addition (30 ng/ml): percentage of DinB-YPet foci that colocalize with mCI features (green);
percentage of mCI features that colocalize with DinB-YPet foci. Time points are grouped into 30 min bins. Error bar represents standard deviation of
biological quadruplicates.

bundle-like structures (Figure 3E). Prior to the introduction
of ciprofloxacin, mCI foci were rarely formed in cells during
normal metabolism (<0.1 mCI foci per cell) consistent with
our previous study (57). Unsurprisingly, we did not detect
colocalization of pol IV with the RecA* probe in untreated
cells (Figure 3E). Upon introduction of ciprofloxacin to
the flow chamber, colocalization remained low during the
early phase of the SOS response (i.e. between 0 and 45
min after treatment). From 45 min after the introduction
of ciprofloxacin, pol IV exhibited significant colocalization
(10–40%) with mCI in cells. This colocalization persisted
into the late stages of SOS (up to 180 min after treatment).
The measured colocalization represents an underestimate
since the mCI probe sub-stoichiometrically labels RecA* filaments. Nevertheless, it is clear that RecA* structures represent a major site for pol IV activity in cells. A much lower
proportion of mCI-labelled RecA* structures, 1–3%, spatially overlap with a pol IV focus (Figure 3E). This indicates

that only a small subset of RecA* structures contain pol IV
at any particular time.
Double-strand break resection by RecBCD creates substrates
for pol IV
We next set out to determine whether the formation of nucleoid associated pol IV foci requires DSB resection via the
RecBCD pathway. We examined the extent of DinB-YPet
focus formation in ciprofloxacin and trimethoprim treated
cells, comparing backgrounds that permitted (recB+ ) or prevented (recB) DSB resection. To separate effects on focus formation from effects on DinB-YPet expression, these
measurements were performed in a lexA(Def) background
(48) (dinB-YPet dnaX-mKate2 lexA[Def]). In these cells,
constitutive cleavage of the mutant LexA repressor results
in constitutive and elevated expression of the SOS induced
genes including DinB-YPet even in the absence of exoge-
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Figure 4. Number of pol IV foci per cell in lexA(Def) cells following ciprofloxacin (30 ng/ml) or trimethoprim (1 g/ml) treatment is recB-dependent. (A)
Upper row: Average projection in time (100 ms × 10 frames) showing DinB-YPet (pol IV) foci. Bottom row: Discoidal filtered projections. Columns 1 and
3: recB+ cells (EAW1141). Columns 2 and 4: recB cells (EAW1144). Cells were treated for 60 min prior to imaging. (B) Percentage of cells containing pol
IV foci: 0 foci (light gray), 1 focus (gray), 2 foci (amber) and ≥3 foci (red). Cells were treated with 30 ng/ml ciprofloxacin (n = 106), 30 ng/ml ciprofloxacin
+ 2% DMSO (n = 109), 30 ng/ml ciprofloxacin in recB (n = 106), 1 g/ml trimethoprim (n = 145), 1 g/ml trimethoprim + 2% DMSO (n = 102), 1
g/ml trimethoprim in recB (n = 94) experienced no damage for wild-type (n = 85) and recB (n = 99). (C) Number of DinB-YPet foci per cell. Error
bars represent standard error of the mean. Number of cells included in analysis: n(untreated recB+ ) = 85, n(untreated recB) = 99, n(trimethoprim) =
145, n(trimethoprim in recB) = 94, n(ciprofloxacin) = 106, n(ciprofloxacin in recB) = 106. * for P < 0.01 in two-sample t-test for differences of means.

nous DNA damage (30). To capture DinB-YPet binding
events, we recorded burst acquisitions of the DinB-YPet signal (Supplementary Movie S2; 300 × 50 ms exposures taken
every 100 ms; for further explanation of method see Supplementary Figure S1A and D).
Consistent with our previous results (30), few DinB-YPet
foci were observed (Figure 4A) in lexA(Def) cells in the absence of either antibiotic (0.08 ± 0.05 foci per cell, Figure 4B
and C), indicating that pol IV rarely binds to the nucleoid
in the absence of exogenous DNA damage. In contrast, cells
treated with trimethoprim for 60 min contained multiple
DinB-YPet foci (2.6 ± 0.2 foci per cell, Figure 4B and C).
Interestingly, trimethoprim-treated recB cells contained
very few foci (0.1 ± 0.05, Figure 4B and C), indicating that
focus formation is strongly recB-dependent. Cells treated
with ciprofloxacin for 60 min exhibited many foci (1.8 ±
0.15 foci per cell, Figure 4B and C), whereas cells lacking
recB again produced very few foci (0.2 ± 0.05 foci per cell,
Figure 4B and C). Taken together these results demonstrate
that the formation of DinB-YPet foci is strongly dependent
on the presence of the recB gene. This, in conjunction with

the significant colocalization of pol IV foci and a RecA*
marker (Figure 3D and E), implies that pol IV is predominantly active at DSB repair intermediates in cells treated
with ciprofloxacin or trimethoprim. Additionally, ROS mitigation, which can reduce the number of DSB per cell (Supplementary Figure S6), also reduced the number of pol IV
foci per cell (Supplementary Figure S15).
Evidence supporting a physical interaction between pol IV
and RecA* in cells
Previous reports (8,38) provided in vitro evidence of a physical interaction between pol IV and RecA, which is likely
to be relevant to its role in homologous recombination. We
next determined whether a physical interaction between pol
IV and RecA* occurs in vivo. Evidence supporting such
an interaction arose from a series of measurements involving a mutant form of RecA. We observed that cells carrying the recA(E38K) mutation (also known as recA730) produce multiple pol IV foci, even in the absence of exogenous
DNA damage (Figure 5; lexA[Def] recA[E38K]: 1.2 ± 0.2
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foci per cell; lexA[Def] recA+ : 0.2 ± 0.1; lexA+ recA+ : 0.1 ±
0.05). A strain expressing a catalytically dead version of the
pol IV probe (dinB[D103N-YPet]) produced a similar number of foci to the strain expressing the catalytically competent probe (Supplementary Figure S16), indicating that foci
formed in the recA(E38K) background are unlikely to represent pol IV molecules engaged in DNA synthesis.
In vitro, the RecA(E38K) mutant protein readily forms
RecA*-like structures that are each competent for LexA
cleavage on both ssDNA and dsDNA (Supplementary
Figure S17 and 18). In vivo, RecA(E38K) constitutively
promotes induction of the SOS response (83). Since
RecA(E38K) readily binds dsDNA in vitro and cleaves
LexA on dsDNA-RecA(E38K) filaments, we suggest that
in the absence of exogenous DNA damage, most of the
RecA(E38K)* structures in cells would form on dsDNA.
In undamaged recA(E38K) cells, pol IV could form foci as
it physically associates (unproductively) with these dsDNAnucleated RecA(E38K)* structures. Surface plasmon resonance analysis confirmed such an interaction occurs in vitro
(Supplementary Figure S17E and F). In wild-type (recA+ )
cells, foci would form as pol IV associates with RecA* structures that form as intermediates during DSB repair following ciprofloxacin or trimethoprim treatment. In sum,
we infer from the data that pol IV physically interact with
RecA(E38K)* structures in vivo and observe that pol IV and
mCI colocalize at sites of RecA* filaments. From this, we
infer that in wild-type cells pol IV physically interacts with
RecA* filament structures engaged in homologous recombination.

Focus formation by pol V does not correlate with DSBs
Finally, we used the single-molecule imaging approach to
explore if the formation of DSBs affected the nucleoidbinding activity of the other major error-prone polymerase
present in E. coli, pol V (UmuD 2 C). Formation of the ac-

tive form of pol V, known as pol V Mut (UmuD 2 -UmuCRecA-ATP), occurs through a series of tightly regulated
steps (84,85). In cells, UmuC foci might be expected to form
at two different stages of this activation process; when pol V
Mut is formed through the interaction of pol V (UmuD 2 UmuC) with RecA* filaments (84,85), and when active pol
V Mut complexes synthesize DNA (50).
Since pol V is also a member of the SOS regulon
(31,84), we again used the lexA(Def) background (RW1286,
umuC-mKate2 dnaX-YPet lexA[Def]) to separate effects on
focus formation from effects on UmuC-mKate2 expression. As before, lexA(Def) cells were treated for 60 min
with ciprofloxacin or trimethoprim (Supplementary Figure
S1A). Movies of the UmuC-mKate2 signal were recorded
(for further explanation see Supplementary Figure S1D,
300 × 50 ms exposures taken every 100 ms). We additionally
monitored focus formation in cells that were co-treated with
the ROS-mitigator DMSO, which reduces DSB formation
in both ciprofloxacin- and trimethoprim-treated cells (Figure 1).
Few UmuC-mKate2 foci were observed (Figure 6A) in
the absence of antibiotic in lexA(Def) cells (0.3 ± 0.1
foci per cell, Figure 6B). In lexA(Def) cells treated with
ciprofloxacin or trimethoprim for 60 min, foci were clearly
visible (ciprofloxacin: 1.2 ± 0.2 foci per cell,; trimethoprim 1.4 ± 0.2 foci per cell, Figure 6B). In both cases,
co-treatment with DMSO to reduce the number of DSBs
had little effect on the number of UmuC-mKate2 foci
(ciprofloxacin-DMSO: 1.0 ± 0.1 foci per cell; trimethoprimDMSO 1.3 ± 0.2 foci per cell) or on the overall levels of
UmuC-mKate2 fluorescence in the cells. Thus, in contrast
to the effects observed for pol IV (Supplementary Figure
S15), the addition of DMSO had little effect on pol V focus
formation.
In trimethoprim-treated lexA+ cells (SOS is damageinduced) independently of DMSO co-treatment, UmuCmKate2 was primarily associated with the cell membrane (Supplementary Figure S19). In a previous study,
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Figure 5. Formation of pol IV foci in lexA and recA mutants. (A) Images of DinB-YPet and DnaX-mKate2 signals in lexA+ recA+ cells (EAW643).
Left: Average projection of movie, producing an image with an effective exposure time of 300 ms. Right: Merged images of discoidal filtered DinB-YPet
(green) and DnaX-mKate2 signals (magenta). (B) similar analysis for lexA(Def) recA+ cells (RW1594). (C) similar analysis for lexA(Def) recA(E38K) cells
(RW1598). (D) Number of DinB-YPet foci per cell. Error bars represent standard error of the mean. Number of cells included in analysis: n(lexA+ recA+ )
= 112, n(lexA[Def] recA+ ) = 98, n(lexA[Def] recA[E38K]) = 114.
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Figure 7. Model for pol IV extending D loops. Double-strand breaks are processed by the RecBCD helicase-nuclease multiprotein complex. RecBCD
resects breaks and loads RecA on the single-stranded DNA regions, forming RecA* filaments. RecA* filaments are competent to induce the SOS response
while undergoing homology search. Once a homologous sequence is found in the genome, a D loop can form which can be extended by certain DNA
polymerases. Pol IV, for instance, can participate in recombination reactions following RecBCD activity.

we showed that this phenomenon stems from a form of
spatial regulation in which UmuC is only released from
the cell membrane once sufficient cleavage of UmuD2 to
UmuD 2 has taken place (50). Consistent with this, western blots showed that the levels of both UmuD2 and
UmuD 2 were much lower in trimethoprim-treated cells
than in ciprofloxacin-treated cells (Supplementary Figure
S20B and D).

DISCUSSION
Previous work established that pol IV foci increase in response to DNA damage and SOS induction, although most
are not associated with replisomes. The current study extends this work, providing four main conclusions which
intimately link pol IV activity to DSB repair: (i) SOSassociated upregulation of pol IV production in response to
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Figure 6. Measuring the number of pol V foci per cell following ciprofloxacin (30 ng/mL) or trimethoprim (1 g/ml) treatment under normal conditions or
ROS-mitigating (2% DMSO) conditions in lexA(Def) cells. (A) Formation of UmuC-mKate2 foci in lexA(Def) cells (RW1286). Cells were treated for 60 min
prior to imaging. Upper row: unfiltered image of an average projection showing UmuC-mKate2 foci that persist for >1 s (from left to right: ciprofloxacin,
ciprofloxacin-DMSO, trimethoprim, trimethoprim-DMSO). Bottom row: merged image showing UmuC-mKate2 foci in magenta and DnaX-YPet foci in
green (from left to right: ciprofloxacin, ciprofloxacin-DMSO, trimethoprim, trimethoprim-DMSO). Scale bar represents 5 m. (B) Number of UmuCmKate2 foci per cell of foci that persist for >1 s following ciprofloxacin treatments (30 ng/ml). Error bars represent standard error of the mean. Number
of cells included in analysis: n(ciprofloxacin) = 97, n(ciprofloxacin-DMSO) = 109, n(untreated) = 87. (C) Number of UmuC-mKate2 foci per cell of foci
that persist for >1 s following trimethoprim treatments (1 g/ml). Error bars represent standard error of the mean. Number of cells included in analysis:
n(trimethoprim) = 102, n(trimethoprim-DMSO) = 120, n(untreated) = 87.
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Pol IV works on recombination intermediates
We showed that the recB gene, which encodes a key component of the RecBCD helicase-nuclease complex that processes DSBs, is required for formation of the vast majority
of pol IV foci formed in cells treated with ciprofloxacin or
trimethoprim (Figure 4). Our observations are consistent
with previously proposed models in which pol IV carries
out repair synthesis during DSB repair (16–24,39,86). The
results described here provide the first indication that once
DSB repair intermediates begin to appear in cells treated
with DSB-inducing antibiotics, they become the predominant substrates for pol IV-dependent DNA synthesis. Prior
to treatment, a small number of pol IV foci are present
(1 focus for every two cells on average, (30)). The majority of these (90%) do not colocalize with replisomes (30).
Beginning 30 min after treatment, the number of mCI features (which form at RecA* structures) steadily increase as
the cells begin to repair DSBs (Figure 3). In parallel there
is a concordant increase in the number of pol IV foci. As
described in our previous work a replisome-proximal subpopulation of pol IV foci remains up until 90 min posttreatment (30). This subpopulation disappears abruptly after 90 min. During the late SOS response (90–180 min after
the onset of treatment) cells contain 2–4 pol IV foci on average. The majority of these foci (90–95%) are recB-dependent
(Figure 4) and many of them colocalize with RecA* structures (Figure 3). The most likely role for pol IV in this context would be extension of D-loop intermediates (Figure 7).
Focus formation by fluorescently tagged pol IV requires
the catalytic activity of pol IV in the wild-type recA+ background (30), suggesting that pol IV might specifically associate with available 3 termini on RecA*-coated substrates,
leading to pol IV-dependent DNA synthesis, as opposed to
binding unproductively along the entire length of the RecA*
nucleoprotein filament. It is important to note that pol IV
is not the sole DNA polymerase charged with carrying out
repair synthesis at DSB repair intermediates; pol III is almost certainly involved (87) and pols I and II likely also play
roles (88–90). Our results instead indicate that when pol
IV acts within cells treated with ciprofloxacin or trimethoprim, it acts within the DSB repair pathway. We hypothesize that D-loop extension by pol IV may be particularly

relevant under conditions of heavy DNA damage, in which
the template strand may itself contain lesions and thus require TLS activity to complete recombination. The observation that a relatively small proportion of RecA* structures contain a spatially overlapping pol IV focus (Figure
3E) indicates that at any particular time, only a subset of
DNA repair-intermediates contain pol IV. There are two
potential explanations for this, which are not mutually exclusive. First, pol IV might bind to a subset of RecA* structures. This would indeed be expected as RecA* structures
are present within multiple intermediates that form during
DSB repair––at end-resected breaks, in molecules undergoing homology search, and in D-loops––yet only D-loops
would be suitable substrates for pol IV-mediated DNA synthesis. Second, binding of pol IV at D-loops may be transient. Here, pol IV would occasionally take over the substrate from pol III, synthesize a short patch of DNA, then
dissociate, handing the substrate back to pol III (Figure 7).
In our previous study, we monitored the formation and loss
of pol IV foci as a function of time, in the milliseconds–
seconds range (30). We observed signal fluctuations that
would be consistent with a scenario in which pol IV remains
bound at substrates for a few hundred milliseconds. This observation, while far from conclusive, is supportive of transient binding. In principle the exchange of pol III for pol
IV at D-loops could occur stochastically, or alternatively,
might be directed by the presence of lesions in the DNA being used as the template for repair synthesis.
The results of the current study support another recent
study, which points to error-prone break repair as a major
mechanism for ciprofloxacin-induced mutagenesis (39). In
the Pribis et al. study, increased mutagenesis was found to
be concentrated within a small sub-population of cells, and
pol IV was found to be a major driver of the increased mutagenesis (along with pols II and V). In principle, this mutagenesis could arise through one of two scenarios. In the first
scenario, pol IV only acts at break-repair intermediates in a
subset of cells, and always acts in an error-prone fashion. In
the second scenario, pol IV acts at repair intermediates in
all cells, but is error-prone in a sub-set of cells. In both the
current study and our microscopy study of pol IV (30), we
observed increases in pol IV expression and focus formation
following ciprofloxacin treatment that were relatively uniform across cells. Our observations appear to be most consistent with the model in which pol IV acts at double-strand
breaks in all cells, but becomes error-prone in a sub-set of
cells that express high levels of RpoS. The mechanism for
this change in the fidelity of pol IV-dependent repair synthesis is not yet clear.
Mutagenic effects that arise from pol IV acting in DSB
repair are now well documented (18–20,36,39). It is pertinent to consider whether another class of pol IV-dependent
phenomena, in which pol IV promotes the survival of cells
exposed to certain alkylating agents (8,17,23,91), might also
stem from pol IV acting at DSB repair intermediates, rather
than at stalled replication forks as is often assumed. Indeed, the authors of a study into the genetic determinants of
4-nitroquinoline-1-oxide resistance concluded that pol IV,
as well as pol II, were likely acting through recombination
pathways (17).
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DSBs induced by trimethoprim or ciprofloxacin treatment
is blocked in a recB mutant (Figures 1–3). (iii) The formation of pol IV foci, which requires the catalytic activity of
pol IV and is indicative of pol IV binding to substrates on
the nucleoid, is drastically reduced in a recB mutant (Figure
4). (iii) Binding of pol IV to the nucleoid involves a physical interaction between pol IV and RecA* nucleoprotein
filaments (Figure 5). (iv) The number of foci formed by the
other Y-family polymerase present in E. coli, pol V, does not
correlate with the number of DSBs formed (Figure 6). From
these results we infer that DSB repair intermediates are the
major substrates for pol IV activity in ciprofloxacin and
trimethoprim treated cells. In contrast, pol V either does not
act in the DSB repair pathway or does so rarely. Thus, pol
IV has a major role in DSB repair that is not shared by pol
V.
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